2007: Vasculitis II
Search
or
Browse by Day
Vasculitis II
Saturday, November 10, 2007
2000
PTPN22 and IRF5 Alleles in Wegener’s Granulomatosis (WG)
2001
Pathogenesis of Allergic Granulomatous Angitis in the Experimental Model with Mice
2002
Cryofibrinogen in Patients with Hepatitis C Virus (HCV)-Mixed Cryoglobulinemia (MC) Vasculitis
2003
Selective p38mapk Isoform Expression and Activation in Anca-Associated Crescentic Glomerulonephritis
2004
Persistent Hematuria after Induction of Remission in Patients with Glomerulonephritis Due to Wegener’s Granulomatosis
2005
Elevated Serum Levels of Soluble CX3CL1 in Patients with Systemic Vasculitis: Potential Involvement in Microscopic Polyangiitis
2006
Cryoglobulinemic Vasculitis in Patients with Chronic HCV Infection. Influence of HCV-RNA Load, HCV Genotype and HIV Coinfection
2007
Association of Cigarette Smoking with Organ Damage in Primary Systemic Vasculitis
2008
Renal Disease Associated with Mixed Cryoglobulinemia Vasculitis Unrelated to Hcv Infection
2009
Efficacy of Rituximab in Limited Wegener’s Granulomatosis with Refractory Granulomatous Manifestations
2010
The Anca Target Antigen Bactericidal/Permeability-Increasing Protein (BPI) Co-Localizes with Gram-Negative Bacterial Outer Membrane Blebs in Lamp-1+ Compartments of Dendritic Cells
2011
Identification of Targets of the Anti-Endothelial Cell Antibodies in Patients with Systemic Vasculitis: By a Proteomic Approach
2012
The Effect of Low-Dose Corticosteroids on Risk of Relapse in ANCA-Associated Vasculitis: A Systematic Review and Meta-Analysis of Clinical Trials
2013
Venous Thromboembolic Events in Patients with Different Systemic Necrotizing Vasculitides: Systematic Study on the French Vasculitis Study Group (FVSG) Patient Cohort
2014
Prevalence of Alpha 1-Antitrypsin (AAT) Deficiency in Wegener’s Granulomatosis (WG)
2015
Regulatory T-Cells in Hepatitis C Virus-Induced Mixed Cryoglobulinemia Vasculitis
2016
Relapse of Hepatitis C Virus-Associated Mixed Cryoglobulinemia Vasculitis in Patients with Sustained Viral Response
2017
The Incidence of Wegener's Granulomatosis and Churg Strauss Syndrome in the UK General Practice Database
2018
Limited Utility of Rapamycin in Severe, Refractory Wegener’s Granulomatosis (WG)
2019
Clinical and Angiographic Features, Treatment and Prognosis of Takayasu’s Arteritis: A Prospective Nationwide Survey in Turkey
2020
Relapses in Rituximab-Treated Wegener’s Granulomatosis Patients Despite Peripheral B Cell Depletion
2021
Long Term Visual Outcome in Patients with Behçet’s Disease
2022
Clinical and Histological Characterization of Vasculitis Involving the Breast
2023
Comparison of Predictors of Relapse in ANCA Vasculitis in 2 Independent Cohorts
2024
Severe Cardiac Involvement in Churg-Strauss Syndrome
2025
Rituximab Combined with Peg-Interferon-Ribavirin in Refractory Hcv-Associated Cryoglobulinemia Vasculitis
See more of:
ACR Abstract Submission Poster Sessions
<< Previous Session Level
|
Next Session Level >>